Literature DB >> 21987409

Prevention of lymphocele in female pelvic lymphadenectomy by a collagen patch coated with the human coagulation factors: a pilot study.

Andrea Tinelli1, Giorgio Giorda, Corrado Manca, Marcello Pellegrino, Raffaele Prudenzano, Marcello Guido, Domenico Dell'Edera, Antonio Malvasi.   

Abstract

BACKGROUND AND OBJECTIVES: The prevention of lymphoceles was tested using collagen patch coated with the human coagulation factors (TachoSil) on 58 consecutive patients with endometrial cancer who had undergone hysterectomy and pelvic lymphadenectomy (PL).
METHODS: Patients were randomized in two groups: standard technique plus TachoSil (30 patients, group 1) and standard technique only (28, group 2). All surgical parameters were collected and patients underwent ultrasound examination on postoperative days 7, 14, and 28. The main outcome measures were: the development of symptomatic or asymptomatic lymphoceles, the need for further surgical intervention, as adverse effect of surgery and the drainage volume and duration.
RESULTS: Same number of lymph nodes in both groups was removed; group 1 showed a lower drainage volume. Lymphoceles developed in 7 patients in group 1 and 16 in group 2, but only 3 were symptomatic in group 1 and 9 symptomatic in group 2, with statistical difference. Percutaneous drainage proved necessary in five cases: only one was in group 1 and four in group 2.
CONCLUSIONS: Intraoperative application of TachoSil reduced rate of postoperative lymphocysts after PL, and it seems to provide a useful additional treatment option for reducing drainage volume and preventing lymphocele development after PL.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987409     DOI: 10.1002/jso.22110

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Comparison of TachoSil and TachoComb in patients undergoing liver resection-a randomized, double-blind, non-inferiority trial.

Authors:  S Kawasaki; H Origasa; V Tetens; M Kobayashi
Journal:  Langenbecks Arch Surg       Date:  2017-04-01       Impact factor: 3.445

2.  Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study.

Authors:  Yun Hwan Kim; Hyun Joo Shin; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2017-02-28       Impact factor: 4.401

3.  A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial.

Authors:  Christoph Grimm; Stephan Polterauer; Samir Helmy; David Cibula; Michal Zikan; Alexander Reinthaller; Clemens Tempfer
Journal:  BMC Cancer       Date:  2014-08-30       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.